These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 375178

  • 1. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications.
    Rajani K, Goetzman BW, Wennberg RP, Turner E, Abildgaard C.
    Pediatrics; 1979 Apr; 63(4):552-6. PubMed ID: 375178
    [Abstract] [Full Text] [Related]

  • 2. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters.
    Ankola PA, Atakent YS.
    Am J Perinatol; 1993 May; 10(3):229-32. PubMed ID: 8517902
    [Abstract] [Full Text] [Related]

  • 3. Prevention of umbilical artery catheter clots with heparinized infusates.
    David RJ, Merten DF, Anderson JC, Gross S.
    Dev Pharmacol Ther; 1981 May; 2(2):117-26. PubMed ID: 7472106
    [Abstract] [Full Text] [Related]

  • 4. Retrospective analysis of risks associated with an umbilical artery catheter system for continuous monitoring of arterial oxygen tension.
    Cohen RS, Ramachandran P, Kim EH, Glasscock GF.
    J Perinatol; 1995 May; 15(3):195-8. PubMed ID: 7666267
    [Abstract] [Full Text] [Related]

  • 5. Continuous blood gas monitoring using an in-dwelling optode method: clinical evaluation of the Neotrend sensor using a luer stub adaptor to access the umbilical artery catheter.
    Rais-Bahrami K, Rivera O, Mikesell GT, Short BL.
    J Perinatol; 2002 May; 22(5):367-9. PubMed ID: 12082470
    [Abstract] [Full Text] [Related]

  • 6. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
    Kulkarni M, Elsner C, Ouellet D, Zeldin R.
    Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
    [Abstract] [Full Text] [Related]

  • 7. Umbilical artery catheters in the newborn: effects of heparin.
    Barrington KJ.
    Cochrane Database Syst Rev; 2000 Feb; 1999(2):CD000507. PubMed ID: 10796377
    [Abstract] [Full Text] [Related]

  • 8. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary artery catheters.
    Zevola DR, Dioso J, Moggio R.
    Am J Crit Care; 1997 Jan; 6(1):52-5. PubMed ID: 9116787
    [Abstract] [Full Text] [Related]

  • 9. Nurses' guide to early detection of umbilical arterial catheter complications in infants.
    Furdon SA, Horgan MJ, Bradshaw WT, Clark DA.
    Adv Neonatal Care; 2006 Oct; 6(5):242-56; quiz 257-60. PubMed ID: 17045945
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M, Heijboer H, van Woensel JB, de Haan RJ.
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [Abstract] [Full Text] [Related]

  • 11. Obtaining blood samples for anti-factor Xa quantification through umbilical artery catheters.
    Edstrom CS, McBride J, Theriaque D, Kao KJ, Christensen RD.
    J Perinatol; 2002 Sep; 22(6):475-7. PubMed ID: 12168126
    [Abstract] [Full Text] [Related]

  • 12. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care.
    Fletcher MA, Brown DR, Landers S, Seguin J.
    Am J Perinatol; 1994 Mar; 11(2):94-9. PubMed ID: 8198665
    [Abstract] [Full Text] [Related]

  • 13. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG.
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [Abstract] [Full Text] [Related]

  • 14. Clinical validation of a continuous intravascular neonatal blood gas sensor introduced through an umbilical artery catheter.
    Meyers PA, Worwa C, Trusty R, Mammel MC.
    Respir Care; 2002 Jun; 47(6):682-7. PubMed ID: 12036438
    [Abstract] [Full Text] [Related]

  • 15. Effect of fluids on life span of peripheral arterial lines.
    Rais-Bahrami K, Karna P, Dolanski EA.
    Am J Perinatol; 1990 Apr; 7(2):122-4. PubMed ID: 2184811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA.
    Arch Intern Med; 1990 Apr; 157(22):2562-8. PubMed ID: 9531224
    [Abstract] [Full Text] [Related]

  • 18. Umbilical artery catheter position and intraventricular hemorrhage.
    Schick JB, Beck AL, DeSilva HN.
    J Perinatol; 1989 Dec; 9(4):382-5. PubMed ID: 2593010
    [Abstract] [Full Text] [Related]

  • 19. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
    Clifton GD, Branson P, Kelly HJ, Dotson LR, Record KE, Phillips BA, Thompson JR.
    Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
    [Abstract] [Full Text] [Related]

  • 20. Elevated plasma tissue factor levels in neonates with umbilical arterial catheter-associated thrombosis.
    Tay SP, Cheong SK, Boo NY.
    Malays J Pathol; 2006 Jun; 28(1):41-8. PubMed ID: 17694958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.